scorecardresearch
Tuesday, Sep 27, 2022
Premium

Reflux drugs may up kidney disease risk: Study

The results showed that individuals who used proton pump inhibitors (PPIs) the most commonly prescribed medications worldwide to reduce gastric acid production, have a potential to increase the risk of chronic kidney disease or kidney failure.

kidney disease, drugs for kidney disease, kidney disease medicines, kidney disease and gastric, indian express, indian express news Stop popping pills. (Source: File Photo)

Regular use of drugs that are commonly used to treat heartburn, acid reflux and ulcers may increase the risk of kidney disease, a study has claimed. According to the study, regular use of proton pump inhibitors (PPIs) like pantoprazole or rabeprazole — the most commonly prescribed medications worldwide to reduce gastric acid production — have a potential to increase the risk of chronic kidney disease or kidney failure.

To investigate the association, researchers led by Charat Thongprayoon from Bassett Medical Centre in New York, US conducted a meta-analysis of five studies with 536,902 participants. The results showed that individuals who used PPIs had a 33 per cent increased relative risk of chronic kidney disease (CKD) or kidney failure when compared with non-users.

“This study demonstrates a significant association between the use of PPIs and increased risks of chronic kidney disease and kidney failure,” Thongprayoon said. “Although no causal relationship has been proven, providers should consider whether PPI therapy is indicated for patients. Chronic use of PPIs should be avoided if not really indicated,” Thongprayoon added.

The findings of the analysis will be presented at ASN Kidney Week 2017 in New Orleans. In a recent study, published in the journal Gut, PPIs users were found to be twice at risk of developing stomach cancer. The study led by researchers from the University of Hong Kong revealed that daily use of PPIs were linked to more than quadrupling in risk of stomach cancer (4.55) compared with weekly use.

Subscriber Only Stories
UPSC Key-September 27, 2022: Why you should read ‘Mankading’ or ‘Rarest o...Premium
Why India has lashed out at the US over its F-16 package to PakistanPremium
Kurmi club: On national path, Nitish looks east, at UP’s Sonelal Pa...Premium
Interview: MD-CEO, Central bank of India | ‘During PCA years, none of our...Premium

The “clear dose-response and time response trend” in the use of PPIs and stomach cancer risk, suggests that doctors “should exercise caution when prescribing long-term PPIs”, the researchers noted.

First published on: 06-11-2017 at 04:06:59 pm
Next Story

Sri Lanka selector Graeme Labrooy defends dropping of Kusal Mendis for India tour

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement